Evidence map›Paper›PMID 35300980›Full record

ArticleThe Journal of biological chemistry2022

Multiubiquitination of TRPV4 reduces channel activity independent of surface localization.

William H Aisenberg, Brett A McCray, Jeremy M Sullivan, Erika Diehl, Lauren R DeVine, Jonathan Alevy, Anna M Bagnell, Patrice Carr, Jack K Donohue, Benedikt Goretzki and 3 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

William H AisenbergDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Brett A McCrayDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jeremy M SullivanDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Erika DiehlDepartment of Chemistry, Biochemistry Section, Johannes Gutenberg-Universität Mainz, Mainz, Germany.
Lauren R DeVineDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jonathan AlevyDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Anna M BagnellDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Patrice CarrDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jack K DonohueDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Benedikt GoretzkiInstitute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence 'Balance of the Microverse', Friedrich-Schiller-Universität, Jena, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universität, Frankfurt am Main, Germany.
Robert N ColeInstitute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence 'Balance of the Microverse', Friedrich-Schiller-Universität, Jena, Germany.
Ute A HellmichInstitute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence 'Balance of the Microverse', Friedrich-Schiller-Universität, Jena, Germany; Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-Universität, Frankfurt am Main, Germany.
Charlotte J SumnerDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: csumner1@jhmi.edu.
Johns Hopkins University · USGoethe University Frankfurt · DEFriedrich Schiller University Jena · DEJohannes Gutenberg University Mainz · DE

Funding

Translating Pathomechanisms into Treatment for Spinal Muscular AtrophiesR35NS122306 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Charlotte Jane Sumner · 2021 to 2026
$6.3M
Pathogenesis of TRPV4-related peripheral neuropathyK08NS102509 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCCRAY, BRETT ANDREW · 2018 to 2022
$997k
LSM880 Laser-scanning Microscope with Airyscan ModuleS10OD023548 · OD · JOHNS HOPKINS UNIVERSITY · PI KUO, SCOT CHARLES · 2018 to 2018
$439k
Exploring disruption of ubiquitination as a mechanism of TRPV4 gain-of-channel function in CMT2CF31NS105404 · NINDS · JOHNS HOPKINS UNIVERSITY · PI AISENBERG, WILLIAM · 2018 to 2019
$90k
NIH HHS S10 OD023548NINDS NIH HHS F31 NS105404NINDS NIH HHS K08 NS102509NINDS NIH HHS R35 NS122306
6 · The paper itself

Abstract

Ubiquitin (Ub)-mediated regulation of plasmalemmal ion channel activity canonically occurs via stimulation of endocytosis. Whether ubiquitination can modulate channel activity by alternative mechanisms remains unknown. Here, we show that the transient receptor potential vanilloid 4 (TRPV4) cation channel is multiubiquitinated within its cytosolic N-terminal and C-terminal intrinsically disordered regions (IDRs). Mutagenizing select lysine residues to block ubiquitination of the N-terminal but not C-terminal IDR resulted in a marked elevation of TRPV4-mediated intracellular calcium influx, without increasing cell surface expression levels. Conversely, enhancing TRPV4 ubiquitination via expression of an E3 Ub ligase reduced TRPV4 channel activity but did not decrease plasma membrane abundance. These results demonstrate Ub-dependent regulation of TRPV4 channel function independent of effects on plasma membrane localization. Consistent with ubiquitination playing a key negative modulatory role of the channel, gain-of-function neuropathy-causing mutations in the TRPV4 gene led to reduced channel ubiquitination in both cellular and Drosophila models of TRPV4 neuropathy, whereas increasing mutant TRPV4 ubiquitination partially suppressed channel overactivity. Together, these data reveal a novel mechanism via which ubiquitination of an intracellular flexible IDR domain modulates ion channel function independently of endocytic trafficking and identify a contributory role for this pathway in the dysregulation of TRPV4 channel activity by neuropathy-causing mutations.

Indexed as

TRPV Cation ChannelsUbiquitinationAnimalsCalciumCell MembraneDrosophilaHumansMiceMutationUbiquitinCalciumTRPV Cation ChannelsUbiquitinchannel activationCharcot–Marie–Tooth diseaseion channelNEDD4plasma membraneTRPV4ubiquitination

Identifiers

PMID35300980
PMCPMC9010760
OpenAlexW4221080620

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.